Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Determinants of Isolated CNS Relapse in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia. from Graall-2005 to -2014 Trials

Blood (2024) 144 (Supplement 1): 731.

https://doi.org/10.1182/blood-2024-198614

Published: 2024

Journal Articles

Fms-like Tyrosine Kinase 3 Ligand Kinetic Profile Is the Strongest Factor Predicting Refractoriness after Induction and Event-Free Survival in Adults with AML: A Filo Prospective Multicentric Study

Blood (2023) 142 (Supplement 1): 975.

https://doi.org/10.1182/blood-2023-173518

Published: 2023

Journal Articles

CPX-351 in Patients with Newly Diagnosed Post Myeloproliferative Neoplasms Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2917.

https://doi.org/10.1182/blood-2023-184591

Published: 2023

Journal Articles

Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 537–538.

https://doi.org/10.1182/blood-2022-165464

Published: 2022

Journal Articles

Number of Mutations and Type of Prior Myeloproliferative Neoplasm Are Prognostic Factors in Acute Myeloid Leukemia Post Myeloproliferative Neoplasms

Edmond Chiche, Sarah Bonnet, Sarah Bertoli, MD PhD, Andrew T Kuykendall, MD, Lauris Gastaud, Pascal Boulay, Veronique De Mas, Eric Delabesse, MD PhD, Alice Marceau-Renaut, Claude Preudhomme, Anne Murati, David A Sallman, MD, S. Dominique Raynaud, MD, Christian Recher, MD PhD, Norbert Vey, MD PhD, Thomas Cluzeau, MD PhD

Blood (2018) 132 (Supplement 1): 2806.

https://doi.org/10.1182/blood-2018-99-114428

Published: 2018

Journal Articles

Daratumumab in Combination with Dexamethasone in Resistant or Refractory Multiple Myeloma: Primary Results of the IFM2014-04 Trial

Eileen Mary Boyle, MD MSc, Marie-Odile Petillon, MD, Charles Herbaux, MD, Johanna Mimouni, Xavier Leleu, Lionel Karlin, MD, Chantal Doyen, MD, Marc Wetterwald, MD PhD, Muriel Roussel, MD, Cyrille Hulin, Bruno Royer, MD, Margaret Macro, Philippe Moreau, Karel Fostier, MD, Mamoun Dib, Sabine Brechignac, MD, Caroline Bureau, Gerald Marit, MD, Adrian Tempescul, MD, Marie Lorraine Chretien, Charles Zarnitsky, Cecile Fohrer, MD, Aurore Perrot, MD, Lotfi Benboubker, MD PhD, Laurent Voillat, Jean Valere Malfuson, Clara Mariette, Mourad Tiab, Sophie Rigaudeau, Arnaud Jaccard, MD PhD, Anne-Marie Stoppa, Laure Vincent, Jean Claude Eisenmann, MD, Laurent Frenzel, Bertrand Arnulf, MD, Mohamad Mohty, MD PhD, Philippe Rodon, MD, Brigitte Kolb, Olivier Decaux, MD PhD, Pascal Godmer, David Beauvais, Benjamin Carpentier, Sarah Bonnet, MD, Thomas Longval, Mathieu Dewevre, Herve Avet-Loiseau, MD PhD, Michel Attal, Susanna Schraen, PharmD, Thierry Facon

Blood (2016) 128 (22): 2138.

https://doi.org/10.1182/blood.V128.22.2138.2138

Published: 2016

Journal Articles

Preclinical Evaluation of Ibrutinib for Central Nervous System Lymphoma

Frederic Pouzoulet, PhD, Keyvan Rezai, PhD, Zhimin Li, PhD, Qiu Yushi, Han W Tun, MD, Dalila Labiod, Engeneer, Sarah Bonnet-Boissinot, Engineer, Carole Soussain, MD PhD

Blood (2016) 128 (22): 4170.

https://doi.org/10.1182/blood.V128.22.4170.4170

Published: 2016

Journal Articles

Can Assessment of Patient Monoclonal Immunoglobulins By Heavy/Light Analysis be Used to Assign Patient Responses Analogous to IMWG Response Criteria?

Eileen Boyle, Guillemette Fouquet, Julie Lejeune, Salomon Manier, MD, Lucile Musset, Claire Bories, Remy Dulery, MD, Stéphanie Guidez, Sarah Bonnet, Brigitte Onraed, Jean-Luc Faucompre, Sabine Tricot, Stephanie Poulain, Veronique Leblond, MD PhD, Kym Snell, Xavier Leleu, MD

Blood (2015) 126 (23): 3042.

https://doi.org/10.1182/blood.V126.23.3042.3042

Published: 2015

Journal Articles

Comparison of Waldenstrom Macroglobulinemia Responses Using Immunoglobulin Heavy / Light Chain Analysis and Conventional Electrophoresis Techniques

Eileen M Boyle, MD, Julie Lejeune, Salomon Manier, MD, Lucile Musset, MD, Claire Bories, MD, Remy Dulery, Stéphanie Guidez, Sarah Bonnet, MD, Guillemette Fouquet, MD, Brigitte Onraed, MD, Jean-Luc Faucompré, MD, Sabine Tricot, MD, Stephanie Poulain, Veronique Leblond, MD PhD, Xavier Leleu, MD, Stephen Harding, PhD

Blood (2014) 124 (21): 2978.

https://doi.org/10.1182/blood.V124.21.2978.2978

Published: 2014

Journal Articles

Prognostic Of IgD Myeloma In The Era Of Novel Agents

Blood (2013) 122 (21): 1880.

https://doi.org/10.1182/blood.V122.21.1880.1880

Published: 2013

Journal Articles

Impact Of Initial FGD-PET CT and Serum Free Light Chain On Transformation Of Solitary Plasmacytoma To MM

Guillemette Fouquet, MD, Stéphanie Guidez, MD, Charles Herbaux, MD, Zoé Van de Wyngaert, MD, Sarah Bonnet, MD, David Beauvais, MD, Helene Demarquette, MD, Bénédicte Hivert, MD, Mathieu Wemeau, MD, Louis Terriou, MD, Valérie Coiteux, Margaret Macro, MD, Olivier Decaux, MD, Thierry Facon, MD, Damien Huglo, MD, PhD, Xavier Leleu, MD, PhD

Blood (2013) 122 (21): 1888.

https://doi.org/10.1182/blood.V122.21.1888.1888

Published: 2013

Journal Articles

Long-Term Follow-Up Of Invasive Aspergillosis In Allogeneic Stem Cell Transplantation Recipients and Leukemia Patients: Differences In Risk Factors and Outcoumes

Sarah Bonnet, MD, Remy Dulery, MD, Khalid Regany, MD, Serge Alfandari, MD, Malek Bouketouche, MD, Zoé Van de Wyngaert, MD, Benjamin Carpentier, MD, Jordan Gauthier, MD, Leonardo Magro, MD, Céline Berthon, MD, PhD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2013) 122 (21): 4568.

https://doi.org/10.1182/blood.V122.21.4568.4568

Published: 2013

Journal Articles

Safety Profile Of Bortezomib Impacts Survival Of Cardiac AL Amyloidosis

Zoé Van de Wyngaert, MD, Greg Vanoutryve, Charles Herbaux, MD, Guillemette Fouquet, MD, Helene Demarquette, MD, Sarah Bonnet, MD, David Beauvais, MD, Stéphanie Guidez, MD, Nicolas Lamblin, MD, Eric Hachulla, MD, PhD, David Launay, Louis Terriou, MD, Bénédicte Hivert, MD, Mathieu Wemeau, MD, Xavier Leleu, MD, PhD

Blood (2013) 122 (21): 5316.

https://doi.org/10.1182/blood.V122.21.5316.5316

Published: 2013

Journal Articles

IgA Hevylite® Test As a Surrogate to Serum Protein Electrophoresis (SPEP) or Nephelometry in the Management of IgA Myeloma

Eileen Mary Boyle, MD, Philip Young, Helene Demarquette, MD, Julie Gay, MD, Houria Debarri, MD, Sarah Bonnet, MD, Charles Herbaux, MD, Remy Dulery, MD, Salomon Manier, MD, Jean-Luc Faucompre, Frederic Combat, MD, Annie Pietrantuono, MD, Brigitte Onraed, Bernadette Hennache, Thierry Facon, MD, Stephen J Harding, MD, PhD, Xavier Leleu, MD, PhD

Blood (2012) 120 (21): 3970.

https://doi.org/10.1182/blood.V120.21.3970.3970

Published: 2012

Journal Articles

Efficacy and Safety Profile of Long Term Exposure to Lenalidomide in Relapsed Multiple Myeloma.

Guillemette Fouquet, MD, Stéphanie Tardy, MD, Helene Demarquette, MD, Sarah Bonnet, MD, Julie Gay, MD, Houria Debarri, MD, Charles Herbaux, MD, Jessica Michel, MD, Aurore Perrot, MD, Caroline Serrier, MD, Suzanne K. Robinson, PhD, Darko Miljkovic, Pascale Morel, Catherine Boccacio, Herve AvetLoiseau, MD, Thierry Facon, MD, Cyrille Hulin, MD, Xavier Leleu, MD, PhD

Blood (2012) 120 (21): 2964.

https://doi.org/10.1182/blood.V120.21.2964.2964

Published: 2012

NARROW

Determinants of Isolated CNS Relapse in Adults with Philadelphia-Negative Acute Lymphoblastic Leukemia. from Graall-2005 to -2014 Trials

Fms-like Tyrosine Kinase 3 Ligand Kinetic Profile Is the Strongest Factor Predicting Refractoriness after Induction and Event-Free Survival in Adults with AML: A Filo Prospective Multicentric Study

CPX-351 in Patients with Newly Diagnosed Post Myeloproliferative Neoplasms Acute Myeloid Leukemia

Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia

Number of Mutations and Type of Prior Myeloproliferative Neoplasm Are Prognostic Factors in Acute Myeloid Leukemia Post Myeloproliferative Neoplasms

Daratumumab in Combination with Dexamethasone in Resistant or Refractory Multiple Myeloma: Primary Results of the IFM2014-04 Trial

Preclinical Evaluation of Ibrutinib for Central Nervous System Lymphoma

Can Assessment of Patient Monoclonal Immunoglobulins By Heavy/Light Analysis be Used to Assign Patient Responses Analogous to IMWG Response Criteria?

Comparison of Waldenstrom Macroglobulinemia Responses Using Immunoglobulin Heavy / Light Chain Analysis and Conventional Electrophoresis Techniques

Prognostic Of IgD Myeloma In The Era Of Novel Agents

Impact Of Initial FGD-PET CT and Serum Free Light Chain On Transformation Of Solitary Plasmacytoma To MM

Long-Term Follow-Up Of Invasive Aspergillosis In Allogeneic Stem Cell Transplantation Recipients and Leukemia Patients: Differences In Risk Factors and Outcoumes

Safety Profile Of Bortezomib Impacts Survival Of Cardiac AL Amyloidosis

IgA Hevylite® Test As a Surrogate to Serum Protein Electrophoresis (SPEP) or Nephelometry in the Management of IgA Myeloma

Efficacy and Safety Profile of Long Term Exposure to Lenalidomide in Relapsed Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only